Review Article
Open Access
Antioxidants In The Management of
Sickle Cell Anaemia
*Obeagu Emmanuel Ifeanyi1, Ekelozie Ifeoma Stella2 and Anyiam Arinze Favour2
1Medical Laboratory Services, Department of University Health Services, Michael Okpara University of Agriculture, Umudike, Abia
State, Nigeria
2Department of Medical Laboratory Science, Nnamdi Azikiwe University, Nnewi Campus, Anambra State, Nigeria
2Department of Medical Laboratory Science, Nnamdi Azikiwe University, Nnewi Campus, Anambra State, Nigeria
*Corresponding author: Obeagu Emmanuel Ifeanyi, Medical Laboratory Services, Department of University Health Services, Michael Okpara University
of Agriculture, Umudike, Abia State, Nigeria; Tel:+2348037369912; E-mail:
@
Received: August 23, 2018; Accepted: September 17, 2018; Published: September 18, 2018
Citation: Obeagu Emmanuel I, Ifeoma Stella E, Anyiam AF (2018) Antioxidants In The Management of Sickle Cell Anaemia. Int J Hematol Blo Dis 3(2). 1-2
Abstract
The burden of anaemia associated with sicke cell disease is major
haemoglobinopathies causing a lot of challenge globally. It is still
highly prevalent in Nigeria not minding all the efforts to reduce the
menace. It presents with so many challenges and complications to
the patients. A lot of efforts are going on to enhance the lives of the
patients. Sickle cell anaemia patients have hype metabolic rates with
elevated production of reactive oxygen free radicals (OFRs) which are
destructive to cells especially if there is low total antioxidant status as
seen among sickle cell anaemia patients. It is important to administer
enough foods and fruits that are rich in antioxidants to improve the
well-being of the patients. This paper was written to enlighten the
world and those involved with the care of sickle cell patients on the
need to manage them with antioxidants and the resultant positive
effect that will ensue on the patients.
Keywords: Antioxidants; Management; Sickle Cell Anaemia; Crisis
Keywords: Antioxidants; Management; Sickle Cell Anaemia; Crisis
Introduction
Sickle cell anaemia is a genetic condition which is marked
by sickling of red blood cell (RBCs) under deoxygenation [1]. It
is highly prevalent among African descents especially in areas
malaria infection is endemic because of selective advantage of
sickle cell trait [2]. Sickle cell patients are still seen in Nigeria
upon all the efforts for genetic counseling before marriage made
by the health workers. Sickle cell anaemia is a point mutation
in β- globin chain. There is indication that there is increased
oxidation in sickle cell subjects in relation to healthy individuals
with increased release of reactive radicals which are highly
damaging to the cells in the system of the patient leading to crisis
in them with resultant shortened life span if not handled properly.
There is reduction in total antioxidants status of the subjects with
exacerbation of pains in them [3, 4].
A certain level of oxidation happens in majority of human diseases and is suspected to make a significant contribution to the process leading to the disease formation [1]. Little of oxygen free radicals (OFRs) are usually produced in aerobic organisms. Reduced OFRs are shown to be important in most of cellular processes, but retenton of OFRs may destroy biological macromolecules, resulting to cytotoxicity, hypersentivity, mutagenicity and /or carcinogenicity [5].
A certain level of oxidation happens in majority of human diseases and is suspected to make a significant contribution to the process leading to the disease formation [1]. Little of oxygen free radicals (OFRs) are usually produced in aerobic organisms. Reduced OFRs are shown to be important in most of cellular processes, but retenton of OFRs may destroy biological macromolecules, resulting to cytotoxicity, hypersentivity, mutagenicity and /or carcinogenicity [5].
Role of Antioxidants
The antioxidant defense against free radicals attack may
be responsible for the susceptibility to disease pathogenesis as
some studies have shown reduced antioxidant levels in some
patients [6, 7].
Free radicals are not completely decreased chemical species that have a single unpaired electron in an outer orbit. Energy created by these unstable elements is given through reactions with adjacent molecules, with the capacity to destroy lipids, proteins and nucleic acids [8]. Autocatalytic reactions stimulated by free radicals change susceptible molecule to free radicals to produce the chain destruction [9, 10]. Free radical attack has been associated to numerous disease situations [1].
Some antioxidants like Vitamin E, Vitamin A and ascorbic acid and reduced glutathione in the cytosol [6] inhibit the initiation of free radical destruction. Also, some enzymatic systems lead to the inactivation of free radical reactions. These break down hydrogen peroxide and superoxide anion. The enzymes are often positioned near the sites of production of the oxidants. Catalase present in peroxisomes decompose hydrogen peroxide, H2O2 (2H2O2→ O2 +2H2O). Superoxide dismutase’s seen in many cell types change superoxide’s to inactivate molecules, H2O2 (2O2- +2H→ H2O2 + O2) [11]. This group is shown to involve both the manganesesuperoxide dismutase which is seen in the cytosol. Glutathione also gives defense against cellular damage by detoxifying oxygen free radicals.
Where there is insufficient antioxidant function, cells undergo serial biochemical and morphologic alterations as they are continuously injured and ultimately causing apoptosis. In a lot of disease situations, the outcome of promoted free radical synthesis is related to the net balance between free radical formation and termination.
Also to serving as an oxygen radical scavenger γ- tocopherol scavenges reactive nitric oxide species and hinders prostaglandin E2 have been shown to mediate inflammation [12]. Other amine antioxidants function as lipid peroxide and scavenge ROS [9, 10]. Individuals confirmed with Sickle cell disease have a greater requirement for the antioxidant (Glutathione) to facilitate metabolic processes, than healthy individuals.
The total antioxidant status (TAS) is reported reduced in sickle cell anaemia due to increased release of oxygen free radicals (OFRs) generated in the body by the metabolic processes. Sickle cell patients are faced with many complications that could lead to increase release of OFRs to overwhelm the antioxidant status. Adequate administration of antioxidants will be of great help to improve the well-being of the patients. The patients should eat food and fruits rich in antioxidants to build their immunity and naturally fight many opportunistic infections that enhance release of OFRs that could lead to apoptosis of cells with attendant shortened life.
Free radicals are not completely decreased chemical species that have a single unpaired electron in an outer orbit. Energy created by these unstable elements is given through reactions with adjacent molecules, with the capacity to destroy lipids, proteins and nucleic acids [8]. Autocatalytic reactions stimulated by free radicals change susceptible molecule to free radicals to produce the chain destruction [9, 10]. Free radical attack has been associated to numerous disease situations [1].
Some antioxidants like Vitamin E, Vitamin A and ascorbic acid and reduced glutathione in the cytosol [6] inhibit the initiation of free radical destruction. Also, some enzymatic systems lead to the inactivation of free radical reactions. These break down hydrogen peroxide and superoxide anion. The enzymes are often positioned near the sites of production of the oxidants. Catalase present in peroxisomes decompose hydrogen peroxide, H2O2 (2H2O2→ O2 +2H2O). Superoxide dismutase’s seen in many cell types change superoxide’s to inactivate molecules, H2O2 (2O2- +2H→ H2O2 + O2) [11]. This group is shown to involve both the manganesesuperoxide dismutase which is seen in the cytosol. Glutathione also gives defense against cellular damage by detoxifying oxygen free radicals.
Where there is insufficient antioxidant function, cells undergo serial biochemical and morphologic alterations as they are continuously injured and ultimately causing apoptosis. In a lot of disease situations, the outcome of promoted free radical synthesis is related to the net balance between free radical formation and termination.
Also to serving as an oxygen radical scavenger γ- tocopherol scavenges reactive nitric oxide species and hinders prostaglandin E2 have been shown to mediate inflammation [12]. Other amine antioxidants function as lipid peroxide and scavenge ROS [9, 10]. Individuals confirmed with Sickle cell disease have a greater requirement for the antioxidant (Glutathione) to facilitate metabolic processes, than healthy individuals.
The total antioxidant status (TAS) is reported reduced in sickle cell anaemia due to increased release of oxygen free radicals (OFRs) generated in the body by the metabolic processes. Sickle cell patients are faced with many complications that could lead to increase release of OFRs to overwhelm the antioxidant status. Adequate administration of antioxidants will be of great help to improve the well-being of the patients. The patients should eat food and fruits rich in antioxidants to build their immunity and naturally fight many opportunistic infections that enhance release of OFRs that could lead to apoptosis of cells with attendant shortened life.
Conclusion
It has been shown that antioxidants administration especially
in food and fruits will be highly beneficial to the care of sickle
cell disease subjects. This will help to reduce crisis, inflammation
and shortened life of the patients. The patients are encouraged to
take more fluids and nutritive foods to enhance their well-being
and productivity in life. There is hope for those living with sickle
cell anaemia. Research in antioxidants is becoming more dynamic
and promising and will be utilized to management diseases. More
researches should be done in antioxidant utilization in sickle cell
anaemia to enhance the life of those affected. This will reduce
economic and human loss as a result of this menace that is
genetically formed by point mutation in β- globin chain.
ReferencesTop
- Obeagu EI, Ochei KC, Nwachukwu BN, Nchuma BO. Sickle Cell Anaemia: A Review. Scholars Journal of Applied Medical Sciences (SJAMS). 2015;3(6B):2244 - 2252.
- WHO Genes and human disease. 2014.
- Junior EB, da Silva DG, Torres Lde S, de Almeida EA, Cancado RD, Chiattone C, Bonini-Domingos CR, et al. Oxidative stress and antioxidant capacity in sickle cell anaemia patients receiving different treatments and medications for different periods of time. Annals of hematology. 2012;91(4):479-489. doi: 10.1007/s00277-011-1340-y
- Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, Madden J, Porter J, et al. Oxidative stress and inflammation in iron-overloaded patients with β‐thalassaemia or sickle cell disease. British journal of haematology. 2006;135(2):254-263.
- Asnani M R, A M McCaw-Binns and M E Reid. Excess risk of maternal death from sickle cell disease in Jamaica: 1998–2007. PloS one. 2011;6(10):e26281.
- Kalra J, Mantha SV, Prassad K. Oxygen-free Radicals: Key Factors in Clinical Diseases. Lab Medica International. 1994;11(2):16-21.
- Jose M, Mates J, Aledo C, Cristina P, Esteban del Valle A, Jose M, Segura M, et al. Interrelationship between oxidative damage and antioxidant enzyme activities: an easy and rapid experimental approach. Biochem Education. 2000;28(2):93-95.
- Ezimah ACU, Onyeyili PA, Nwobu GO, Nwankwo EA. Glutathione peroxidase levels in Nigerians with AIDS. J Med Lab Sc.2005;14(1):11- 13.
- Barry-Halliwell. Oxygen is poisonous: the nature and medical importance of oxygen radicals. Med Lab Science. 1984;41:157-171.
- Synder JW. Mechanisms of toxic cell injury. Clin Lab Med. 1990;10(2):311-321.
- Kumar V, Abbas AK, Fausto N. Pathologic basis of disease. 7th edition. Elsvier Saunders Pennysylvania. 2005;74:16-18.
- Levy JA. HIV and the pathogenesis of AIDS.2nd edition. ASM Press Washington D C. 1998;75-76.
- Lefrere JJ, Courouce AM, Lambin P, Fine JM, Doinel C, Salmo C. Clinical and Biological features in the 12 months preceding onset of IADSin HIV-infected subjects. Journal of AIDS. 1989;2:100-101.